The Purpose of This Study is to Evaluate the Efficacy and Safety of Sintilimab in Combination With Xelox as Neoadjuvant Therapy for Patients With Resectable Locally Advanced Gastric or Gastroesophageal Adenocarcinoma.
Clinical trial NCT04065282 · UNKNOWN
Trial details
- NCT number
- NCT04065282
- Sponsor
- First Affiliated Hospital of Zhejiang University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-06
- Primary completion
- 2020-03-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.